• name

  PRECIRIX

• homepage url

  www.precirix.com/

• country

  Belgium

• sector

  Healthcare & Health Services

• industry

  Biotechnology

• monthly webtraffic

  528

• monthly webtraffic growth

  −33.42%

• stage

  Series B

• raised capital

  88173508

PRECIRIX is a private biotechnology company that designs and develops precision radiopharmaceuticals for cancer treatment. The company's lead program targets Fibroblast Activation Protein (FAP), with research on multiple isotopes and combination therapies ongoing.